Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy

Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy

BackgroundDiabetic nephropathy is a major complication of diabetes and an established risk factor for cardiovascular events. Lipid abnormalities occur in patients with diabetic nephropathy, which further increase their risk for cardiovascular events. We compared the degree of dyslipidemia among type...

Full description

Bibliographic Details
Main Authors:	Sabitha Palazhy, Vijay Viswanathan
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2017-01-01
Series:	Diabetes & Metabolism Journal
Subjects:	Cardiovascular risk Diabetic nephropathy Dyslipidemia Small, dense low density lipoprotein
Online Access:	https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-41-128.pdf

Similar Items

Dyslipidemia in subclinical hypothyroidism requires assessment of small dense low density lipoprotein cholesterol (sdLDL-C)
by: Saric Maida Seferovic, et al.
Published: (2017-09-01)

Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus
by: Essam Abd-Allha, et al.
Published: (2014-01-01)

FREQUENCY OF MICROALBUMINURIA IN ABNORMAL LIPID METABOLISM AND SUFFERING FROM TYPE II DIABETES MELLITUS
by: Ejaz Ali, et al.
Published: (2021-08-01)

Predictive value of small dense low-density lipoprotein cholesterol for cardiovascular events in Chinese elder diabetes mellitus patients
by: Li Xu, et al.
Published: (2021-04-01)

LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins
by: Juha Vakkilainen, et al.
Published: (2002-04-01)

"LDL SUBCLASS PATTERNS AND ATHEROGENICITY IN NON-INSULIN DEPENDENT DIABETES MELLITUS"
by: F. Kazerouni, et al.
Published: (2004-10-01)

"LDL SUBCLASS PATTERNS AND ATHEROGENICITY IN NON-INSULIN DEPENDENT DIABETES MELLITUS"
by: F. Kazerouni, et al.
Published: (2004-10-01)

Characteristics of the Lipid Profile in Patients with Diabetes Mellitus and Chronic Kidney Disease
by: Albai Oana, et al.
Published: (2017-09-01)

Quercetin improves lipid metabolism via SCAP-SREBP2-LDLr signaling pathway in early stage diabetic nephropathy
by: Jiang X, et al.
Published: (2019-05-01)

Atherogenic dyslipidemia
by: C N Manjunath, et al.
Published: (2013-01-01)

Role of Helicobacter pylori Infection on Diabetic and Lipid Profile in Pre-diabetic Patients
by: Akash Chaudhary, et al.
Published: (2021-03-01)

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies
by: Kausik K. Ray, et al.
Published: (2019-11-01)

Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile
by: Gerly M. van der Vleuten, et al.
Published: (2005-11-01)

Role of dyslipidemia in the development of nephropathy in patients with type 2 diabetes mellitus (literature review)
by: S.I. Ismailov, et al.
Published: (2019-11-01)

N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study
by: Kana Ide, et al.
Published: (2018-03-01)

Appraising risk of development of cardiovascular disease in patients with type 2 diabetes mellitus
by: Shadan Modaresahmadi, et al.
Published: (2018-01-01)

Association of small dense lowdensity lipoprotein cholesterol in type 2 diabetics with coronary artery disease
by: Ya-Ching Huang, et al.
Published: (2014-12-01)

Lipid profile of healthy women during normal pregnancy
by: Diareme Margarita, et al.
Published: (2009-01-01)

Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
by: Alwhaibi M, et al.
Published: (2019-12-01)

Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial
by: Natia Peradze, et al.
Published: (2019-10-01)

Night sleep duration and risk of each lipid profile abnormality in a Chinese population: a prospective cohort study
by: Qiaofeng Song, et al.
Published: (2020-08-01)

Plasma Level of Oxidized Low- Density Lipoprotein in Macroalbuminuric
by: Nakhjavani Manoochehr, et al.
Published: (2009-10-01)

Plasma Level of Oxidized Low- Density Lipoprotein in Macroalbuminuric
by: Manoochehr Nakhjavani, et al.
Published: (2009-10-01)

The DYSlipidemia International Study (DYSIS)-Egypt: A report on the prevalence of lipid abnormalities in Egyptian patients on chronic statin treatment
by: Adel El Etriby, et al.
Published: (2013-09-01)

Dyslipidemia in type 1 diabetes mellitus: Relation to diabetes duration, glycemic control, body habitus, dietary intake and other epidemiological risk factors
by: Hassan M. Mona, et al.
Published: (2015-06-01)

Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes[S]
by: Ying Zhang, et al.
Published: (2016-02-01)

Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia
by: Sunil K Kota, et al.
Published: (2013-01-01)

Is sdLDL a valuable screening tool for cardiovascular disease in patients with metabolic syndrome?
by: Radwa Momtaz Abdelsamie Zaki Khalil, et al.
Published: (2017-12-01)

Assessment of lipid abnormalities and Cardiovascular Risk indices in Type 2 Diabetes Mellitus
by: Sushil Baral, et al.
Published: (2019-10-01)

Small Dense Low-Density Lipoprotein as Risk Factor for Atherosclerosis in Type 2 Diabetes Mellitus
by: Haji Muhammad Rashid, et al.
Published: (2020-09-01)

Atherogenic Plasma Index or Non-High-Density Lipoproteins as Markers Best Reflecting Age-Related High Concentrations of Small Dense Low-Density Lipoproteins
by: Bednarz-Misa, I., et al.
Published: (2022)

Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients
by: Sunghwan Suh, et al.
Published: (2011-10-01)

Associations of genetic variants for adult lipid levels with lipid levels in children. The Generation R Study[S]
by: Ardashel Latsuzbaia, et al.
Published: (2016-12-01)

Persistence of an atherogenic lipid profile after treatment of acute infection with brucella
by: F. Apostolou, et al.
Published: (2009-12-01)

Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China
by: Xiao-Jun Ouyang, et al.
Published: (2018-01-01)

Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic
by: Hsin-hung Chen, et al.
Published: (2007-01-01)

In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy
by: H.C. Geiss, et al.
Published: (2004-08-01)

Profile of type 2 diabetes mellitus without overt complications of diabetes mellitus at a tertiary care center
by: Rajiv Singla, et al.
Published: (2012-01-01)

Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): Results of the Dyslipidemia International Study (DYSIS)
by: Margus Viigimaa, et al.
Published: (2014-01-01)

How realistic are the LDL-C targets in new dyslipidemia guidelines - is it possible to reach the targets?
by: Barış Güngör
Published: (2020-03-01)